APP and Alzheimer disease: Following systemic administration, we demonstrated that probes 2, 4, 6 and 9 with good in vitro performance could rapidly cross BBB and produce significantly brighter NIR fluorescence in the brains of APP/PS1 transgenic AD mice compared to the age-matched WT mice.